Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"

Kos F. T., Yazici O., Civelek B., Seker M., ARIK Z., AKSOY S., ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.126, no.1-2, pp.36-41, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 126 Issue: 1-2
  • Publication Date: 2014
  • Doi Number: 10.1007/s00508-013-0453-9
  • Journal Name: WIENER KLINISCHE WOCHENSCHRIFT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.36-41
  • Keywords: Comorbidity, Charlson Comorbidity Index, Cumulative Illness Rating Scale, Pancreas, Cancer, PHASE-III TRIAL, CO-MORBIDITY, GEMCITABINE, CHEMOTHERAPY, AGE
  • Gazi University Affiliated: No

Abstract

Effect of comorbidity on the treatments that patients receive is not clear, as healthy elderly patients and the elderly with less comorbid diseases are included in the studies. In the present study, the effect of comorbidity on the survival was evaluated using Charlson Comorbidity Index (CCI) and Cumulative Illness Rating Scale (CIRS).